Related Experiment Video
Updated: Oct 2, 2026

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
Mutant Cu, Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS
Cynthia M J Higgins1, Cheolwha Jung, Hongliu Ding
1Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA.
Abstract:
Mutations in Cu, Zn superoxide dismutase (SOD1) cause a fraction of amyotrophic lateral sclerosis (ALS), which involves motoneuron degeneration, paralysis, and death. An acquired activity by mutant SOD1 is responsible for the cellular toxicity, but how mutant SOD1 kills motoneurons is unclear. In transgenic mouse models of ALS, mitochondrial degeneration occurs early, before disease onset, raising the question of how mutant SOD1 damages mitochondria. Here we investigate the intracellular localization of SOD1 in the CNS to determine whether SOD1 is present in mitochondria, where it could directly damage this organelle. We show that endogenous mouse SOD1, wild-type human, and mutant human SOD1 (G93A), when expressed as transgenes, are colocalized with mitochondria in spinal cord by immunofluorescence confocal microscopy. By immunoelectron microscopy, we show that SOD1 is present within mitochondria at similar concentrations as in the cytoplasm. Thus SOD1, in addition to being a cytosolic enzyme, is present inside mitochondria in the CNS.
Insights
Mutations in copper, zinc superoxide dismutase (SOD1) are linked to amyotrophic lateral sclerosis (ALS). This study reveals SOD1 is present within mitochondria in the central nervous system, suggesting a direct role in neurodegeneration.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease.
- Mutations in copper, zinc superoxide dismutase (SOD1) are a known cause of familial ALS.
- Mitochondrial dysfunction is an early event in ALS pathogenesis.
Purpose of the Study:
- To investigate the intracellular localization of SOD1 in the central nervous system (CNS).
- To determine if SOD1 is present in mitochondria, where it could directly contribute to neurotoxicity in ALS.
Main Methods:
- Immunofluorescence confocal microscopy to assess SOD1 localization in mouse spinal cord.
- Immunoelectron microscopy to confirm SOD1 presence within mitochondria.
Main Results:
- Endogenous mouse SOD1, wild-type human SOD1, and mutant human SOD1 (G93A) colocalized with mitochondria in the spinal cord.
- SOD1 was detected within mitochondria at concentrations comparable to the cytoplasm.
Conclusions:
- SOD1 is not exclusively a cytosolic enzyme but is also localized within mitochondria in the CNS.
- This mitochondrial localization of SOD1 provides a potential mechanism for its direct role in motoneuron degeneration in ALS.
More Related Videos
06:53Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase (COX/SDH) Double-labeling Histochemistry
Published on: November 23, 2011
06:35In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Related Concept Videos
ATP Synthase: Mechanism
Satellite Stem Cells and Muscular Dystrophy
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Electron Transport Chain: Complex III and IV